deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease
- Written by PR Newswire
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD).
REYKJAVIK, Iceland, Oct. 24, 2022 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on...
Read more: deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease